Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

p53 mutation and deletion contribute to tumor immune evasion
Si‐Yang Liu, Tianyao Liu, Jiaxuan Jiang, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 12

Showing 12 citing articles:

Molecular mechanisms and therapeutic applications of huaier in breast cancer treatment
Ke-fei Luo, Linxi Zhou, Zi-wei Wu, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 6
Single-Cell RNA Sequencing in Ovarian Cancer: Current Progress and Future Prospects
Zhi Xiong Chong
Progress in Biophysics and Molecular Biology (2025)
Closed Access
A constitutive interferon-high immunophenotype defines response to immunotherapy in colorectal cancer
Amelia Acha‐Sagredo, Pietro Andrei, Kalum Clayton, et al.
Cancer Cell (2025)
Open Access
P53: A key player in diverse cellular processes including nuclear stress and ribosome biogenesis, highlighting potential therapeutic compounds
Gazmend Temaj, Silvia Chichiarelli, Pelin Telkoparan‐Akillilar, et al.
Biochemical Pharmacology (2024) Vol. 226, pp. 116332-116332
Closed Access | Times Cited: 4
Integrated multi-omics profiling reveals a clinically relevant molecular feature and potential therapeutic target on phyllodes tumors of breast
Wei Xu, W. F. Mader, Depeng Wang, et al.
Translational Oncology (2024) Vol. 46, pp. 101998-101998
Open Access | Times Cited: 2
Emerging therapeutic targets in oral squamous cell carcinoma: Insights from genetic alterations
Santosh Patil, Vishnu Priya Veeraraghavan
Oral Oncology Reports (2024) Vol. 10, pp. 100548-100548
Open Access
In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors
Cecilia Pesini, Laura Artal, J. Bernal, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access
Dendritic cell-related hub genes in head-and-neck squamous cell carcinoma: implications for prognosis and immunotherapy
Haiyong Jin, Lei Zheng, Jie Wang, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 7, pp. 3620-3636
Open Access
Assessment of the Circulating PD-1 and PD-L1 Levels and P53 Expression as a Predictor of Relapse in Pediatric Patients with Wilms Tumor and Hypernephroma
Heba A. Sahyon, Nadaa S. Alharbi, Zummar Asad, et al.
Children (2024) Vol. 11, Iss. 9, pp. 1035-1035
Open Access
Mapping the functional network of human cancer through machine learning and pan-cancer proteogenomics
Zhiao Shi, Jonathan T. Lei, John M Elizarraras, et al.
Nature Cancer (2024)
Closed Access
Successful treatment of pulmonary lymphomatoid granulomatosis with PD-1 inhibitor-based regimen: A Case Report and Literature Review
Qi Gao, Xiaoyan Liu, Feifei Wu, et al.
Research Square (Research Square) (2024)
Open Access
Long-term survival in a patient with Li-Fraumeni syndrome–associated giant cell glioblastoma treated with nivolumab: illustrative case
Melissa Mitchell, Andres Restrepo-Orozco, Leonard H. Verhey, et al.
Journal of Neurosurgery Case Lessons (2024) Vol. 8, Iss. 22
Open Access
Page 1

Scroll to top